BRIEF published on 04/30/2024 at 11:05, 6 months 21 days ago New Partnership Between BioMed X Institute and Merck Focuses on Immuno-Oncology Cancer Research BioMed X Institute Immunotherapy Merck Tumor Immunogenicity
PRESS RELEASE published on 04/30/2024 at 11:00, 6 months 21 days ago New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg Biomedical research institute, BioMed X, partners with Merck to develop novel immunotherapeutic strategies to enhance tumor immunogenicity for cancer patients Cancer Research Immunotherapy Merck Tumor Immunogenicity BioMed X
PRESS RELEASE published on 02/06/2024 at 16:00, 9 months 14 days ago New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine BioMed X Institute and Universitatsmedizin Mannheim researchers publish results of collaboration on new neoepitope vaccine in diffuse midline glioma in Science Advances BioMed X Institute Universitatsmedizin Mannheim Neoepitope Vaccine Diffuse Midline Glioma Science Advances
PRESS RELEASE published on 11/07/2023 at 12:00, 1 year ago BioMed X Launches a New Call for Application in Autoimmune Disease Research
PRESS RELEASE published on 10/31/2023 at 17:00, 1 year ago BioMed X and AbbVie Start New Research Project in the USA
PRESS RELEASE published on 06/29/2023 at 11:00, 1 year 4 months ago BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
PRESS RELEASE published on 04/27/2023 at 14:00, 1 year 6 months ago BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
PRESS RELEASE published on 04/04/2023 at 11:00, 1 year 7 months ago BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Published on 11/21/2024 at 12:00, 46 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 46 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 16 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 43 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 46 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:35, 10 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 31 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 16 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 5 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 48 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 38 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
